Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

Article Types

Countries / Regions

Search Results (7)

Search Parameters:
Authors = Hetvi K. Solanki

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
1 pages, 129 KiB  
Correction
Correction: Chavda et al. Peptide-Drug Conjugates: A New Hope for Cancer Management. Molecules 2022, 27, 7232
by Vivek P. Chavda, Hetvi K. Solanki, Majid Davidson, Vasso Apostolopoulos and Joanna Bojarska
Molecules 2025, 30(12), 2579; https://doi.org/10.3390/molecules30122579 - 13 Jun 2025
Viewed by 272
Abstract
In the original publication cited above [...] Full article
24 pages, 1900 KiB  
Review
Nanotechnology-Based Face Masks: Transforming the Cosmetics Landscape
by Vivek P. Chavda, Hetvi K. Solanki, Dixa A. Vaghela, Karishma Prajapati and Lalitkumar K. Vora
Micro 2025, 5(1), 11; https://doi.org/10.3390/micro5010011 - 7 Mar 2025
Viewed by 2543
Abstract
The cosmetic market is constantly evolving and ever-changing, particularly with the introduction and incorporation of nanotechnology-based processes into cosmetics for the production of unique formulations with both aesthetic and therapeutic benefits. There is no doubt that nanotechnology is an emerging technology for cosmetic [...] Read more.
The cosmetic market is constantly evolving and ever-changing, particularly with the introduction and incorporation of nanotechnology-based processes into cosmetics for the production of unique formulations with both aesthetic and therapeutic benefits. There is no doubt that nanotechnology is an emerging technology for cosmetic formulations. Among the numerous cosmetic items, incorporating nanomaterials has provided a greater scope and is commonly utilized in facial masks, hair products, antiaging creams, sunscreen creams, and lipsticks. In cosmetics, nanosized materials, including lipid crystals, liposomes, lipid NPs, inorganic nanocarriers, polymer nanocarriers, solid lipid nanocarriers (SLNs), nanostructured lipid carriers (NLCs), nanofibers, nanocrystals, and nanoemulsions, have become common ingredients. The implementation of nanotechnology in the formulation of face masks will improve its efficacy. Nanotechnology enhances the penetration of active ingredients used in the preparation of face masks, such as peel-off masks and sheet masks, which results in better effects. The emphasis of this review is mainly on the formulation of cosmetic face masks, in which the impact of nanotechnology has been demonstrated to improve the product performance on the skin. Full article
(This article belongs to the Section Microscale Biology and Medicines)
Show Figures

Graphical abstract

46 pages, 39479 KiB  
Review
Artificial Intelligence in Pharmaceutical Technology and Drug Delivery Design
by Lalitkumar K. Vora, Amol D. Gholap, Keshava Jetha, Raghu Raj Singh Thakur, Hetvi K. Solanki and Vivek P. Chavda
Pharmaceutics 2023, 15(7), 1916; https://doi.org/10.3390/pharmaceutics15071916 - 10 Jul 2023
Cited by 456 | Viewed by 65675
Abstract
Artificial intelligence (AI) has emerged as a powerful tool that harnesses anthropomorphic knowledge and provides expedited solutions to complex challenges. Remarkable advancements in AI technology and machine learning present a transformative opportunity in the drug discovery, formulation, and testing of pharmaceutical dosage forms. [...] Read more.
Artificial intelligence (AI) has emerged as a powerful tool that harnesses anthropomorphic knowledge and provides expedited solutions to complex challenges. Remarkable advancements in AI technology and machine learning present a transformative opportunity in the drug discovery, formulation, and testing of pharmaceutical dosage forms. By utilizing AI algorithms that analyze extensive biological data, including genomics and proteomics, researchers can identify disease-associated targets and predict their interactions with potential drug candidates. This enables a more efficient and targeted approach to drug discovery, thereby increasing the likelihood of successful drug approvals. Furthermore, AI can contribute to reducing development costs by optimizing research and development processes. Machine learning algorithms assist in experimental design and can predict the pharmacokinetics and toxicity of drug candidates. This capability enables the prioritization and optimization of lead compounds, reducing the need for extensive and costly animal testing. Personalized medicine approaches can be facilitated through AI algorithms that analyze real-world patient data, leading to more effective treatment outcomes and improved patient adherence. This comprehensive review explores the wide-ranging applications of AI in drug discovery, drug delivery dosage form designs, process optimization, testing, and pharmacokinetics/pharmacodynamics (PK/PD) studies. This review provides an overview of various AI-based approaches utilized in pharmaceutical technology, highlighting their benefits and drawbacks. Nevertheless, the continued investment in and exploration of AI in the pharmaceutical industry offer exciting prospects for enhancing drug development processes and patient care. Full article
(This article belongs to the Special Issue Model-Informed Drug Discovery and Development, 2nd Edition)
Show Figures

Figure 1

30 pages, 5021 KiB  
Review
Potential Anti-SARS-CoV-2 Prodrugs Activated by Phosphorylation and Their Role in the Aged Population
by Vivek P. Chavda, Divya Teli, Pankti C. Balar, Dixa Vaghela, Hetvi K. Solanki, Akta Vaishnav and Lalitkumar Vora
Molecules 2023, 28(5), 2332; https://doi.org/10.3390/molecules28052332 - 2 Mar 2023
Cited by 17 | Viewed by 3387
Abstract
The COVID-19 pandemic has flared across every part of the globe and affected populations from different age groups differently. People aged from 40 to 80 years or older are at an increased risk of morbidity and mortality due to COVID-19. Therefore, there is [...] Read more.
The COVID-19 pandemic has flared across every part of the globe and affected populations from different age groups differently. People aged from 40 to 80 years or older are at an increased risk of morbidity and mortality due to COVID-19. Therefore, there is an urgent requirement to develop therapeutics to decrease the risk of the disease in the aged population. Over the last few years, several prodrugs have demonstrated significant anti-SARS-CoV-2 effects in in vitro assays, animal models, and medical practice. Prodrugs are used to enhance drug delivery by improving pharmacokinetic parameters, decreasing toxicity, and attaining site specificity. This article discusses recently explored prodrugs such as remdesivir, molnupiravir, favipiravir, and 2-deoxy-D-glucose (2-DG) and their implications in the aged population, as well as investigating recent clinical trials. Full article
Show Figures

Figure 1

22 pages, 2598 KiB  
Review
Omicron Variant of SARS-CoV-2: An Indian Perspective of Vaccination and Management
by Vivek P. Chavda, Pankti Balar, Dixa Vaghela, Hetvi K. Solanki, Akta Vaishnav, Vivek Hala and Lalitkumar Vora
Vaccines 2023, 11(1), 160; https://doi.org/10.3390/vaccines11010160 - 11 Jan 2023
Cited by 34 | Viewed by 6328
Abstract
Omicron variants have highly influenced the entire globe. It has a high rate of transmissibility, which makes its management tedious. There are various subtypes of omicron, namely BA.1, BA.2, BA.3, BA.4, and BA.5. Currently, one omicron subvariant BF.7 is also immersed in some [...] Read more.
Omicron variants have highly influenced the entire globe. It has a high rate of transmissibility, which makes its management tedious. There are various subtypes of omicron, namely BA.1, BA.2, BA.3, BA.4, and BA.5. Currently, one omicron subvariant BF.7 is also immersed in some parts of India. Further studies are required for a better understanding of the new immersing SARS-CoV-2 subvariant of the omicron. They differ in the mutation of the spike proteins, which alters their attachment to the host receptor and hence modifies their virulence and adaptability. Delta variants have a great disastrous influence on the entire world, especially in India. While overcoming it, another mutant catches the pace. The Indian population is highly affected by omicron variants. It alters the entire management and diagnosis system against COVID-19. It demanded forcemeat in the health care system, both qualitatively and quantitively, to cope with the omicron wave. The alteration in spike protein, which is the major target of vaccines, leads to varied immunization against the subvariants. The efficacy of vaccines against the new variant was questioned. Every vaccine had a different shielding effect on the new variant. The hesitancy of vaccination was a prevalent factor in India that might have contributed to its outbreak. The prevalence of omicron, monkeypox, and tomato flu shared some similarities and distinct features when compared to their influence on the Indian population. This review emphasizes the changes omicron brings with it and how the Indian health care system outrage this dangerous variant. Full article
(This article belongs to the Section Vaccines, Clinical Advancement, and Associated Immunology)
Show Figures

Figure 1

17 pages, 1040 KiB  
Review
The Vaccine World of COVID-19: India’s Contribution
by Vivek P. Chavda, Disha R. Vihol, Hetvi K. Solanki and Vasso Apostolopoulos
Vaccines 2022, 10(11), 1943; https://doi.org/10.3390/vaccines10111943 - 17 Nov 2022
Cited by 20 | Viewed by 9387
Abstract
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) eruption has left not only illness and mortality in its wake, but also an overwhelming threat to health policy, human regality, food security, and struggle worldwide. The accessibility and potential distribution of a protective and [...] Read more.
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) eruption has left not only illness and mortality in its wake, but also an overwhelming threat to health policy, human regality, food security, and struggle worldwide. The accessibility and potential distribution of a protective and successful vaccination to communities throughout the world are being considered now not just, as a potential of overcoming these hurdles, but also as an example of human perseverance in the face of catastrophe. A vaccine is the only tool that can efficaciously deal with the COVID-19 catastrophe. Currently, more than 47 vaccines are permitted for emergency use in distinct parts of the world. India will play a significant role in the development of the high-priced Moderna shots and Pfizer Inc, therefore assisting in the immunization of a large portion of the world. Moreover, many of the internationally researched and developed vaccine laboratories seek manufacturing in Indian firms and companies for efficient and low-cost production of vaccines intending to provide to the world, hence, making India, a major role player during these pandemic times. This review highlights the Indian contribution to the globe for COVID-19 management. Full article
(This article belongs to the Special Issue Immune Responses to SARS-CoV-2 Infection and Vaccination)
Show Figures

Figure 1

28 pages, 1455 KiB  
Review
Peptide-Drug Conjugates: A New Hope for Cancer Management
by Vivek P. Chavda, Hetvi K. Solanki, Majid Davidson, Vasso Apostolopoulos and Joanna Bojarska
Molecules 2022, 27(21), 7232; https://doi.org/10.3390/molecules27217232 - 25 Oct 2022
Cited by 68 | Viewed by 10552 | Correction
Abstract
Cancer remains the leading cause of death worldwide despite advances in treatment options for patients. As such, safe and effective therapeutics are required. Short peptides provide advantages to be used in cancer management due to their unique properties, amazing versatility, and progress in [...] Read more.
Cancer remains the leading cause of death worldwide despite advances in treatment options for patients. As such, safe and effective therapeutics are required. Short peptides provide advantages to be used in cancer management due to their unique properties, amazing versatility, and progress in biotechnology to overcome peptide limitations. Several appealing peptide-based therapeutic strategies have been developed. Here, we provide an overview of peptide conjugates, the better equivalents of antibody-drug conjugates, as the next generation of drugs for required precise targeting, enhanced cellular permeability, improved drug selectivity, and reduced toxicity for the efficient treatment of cancers. We discuss the basic components of drug conjugates and their release action, including the release of cytotoxins from the linker. We also present peptide-drug conjugates under different stages of clinical development as well as regulatory and other challenges. Full article
(This article belongs to the Special Issue Advances in Research of Short Peptides II)
Show Figures

Figure 1

Back to TopTop